About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Aarti Pharmalabs Ltd.
BSE Code
543748
ISIN Demat
INE0LRU01027
Book Value
188.35
NSE Code
AARTIPHARM
Dividend Yield %
0.53
Market Cap
51711.20
P/E
25.08
EPS
22.75
Face Value
5
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
20-Dec-2024
569.85
582.50
565.00
570.60
18425
10550860
19-Dec-2024
550.25
581.00
550.25
572.25
552649
312598010
18-Dec-2024
590.00
590.00
560.70
565.10
29543
16903296
17-Dec-2024
607.95
607.95
580.80
584.35
16538
9723986
16-Dec-2024
615.85
615.85
600.50
602.85
7439
4514822
13-Dec-2024
601.60
616.65
589.65
606.85
19665
11780268
12-Dec-2024
608.00
625.00
598.10
601.65
19627
11985116
11-Dec-2024
608.05
612.40
603.30
608.95
12876
7823502
10-Dec-2024
617.05
626.35
603.00
606.75
6372
3890517
09-Dec-2024
632.90
636.00
620.50
621.85
15134
9479005
06-Dec-2024
642.20
645.90
630.00
632.85
4585
2924869
05-Dec-2024
660.00
660.00
641.50
644.05
6791
4392485
04-Dec-2024
655.60
659.20
644.45
656.00
5637
3684509
03-Dec-2024
660.00
673.15
655.25
659.00
9689
6409212
02-Dec-2024
624.95
658.45
624.95
653.00
16514
10640307
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.